vs

Side-by-side financial comparison of CLOVER HEALTH INVESTMENTS, CORP. (CLOV) and UDR, Inc. (UDR). Click either name above to swap in a different company.

CLOVER HEALTH INVESTMENTS, CORP. is the larger business by last-quarter revenue ($487.7M vs $425.8M, roughly 1.1× UDR, Inc.). UDR, Inc. runs the higher net margin — 44.6% vs -10.1%, a 54.7% gap on every dollar of revenue. On growth, CLOVER HEALTH INVESTMENTS, CORP. posted the faster year-over-year revenue change (44.7% vs 0.9%). Over the past eight quarters, CLOVER HEALTH INVESTMENTS, CORP.'s revenue compounded faster (18.6% CAGR vs 1.3%).

Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.

UDR, Inc. is a leading U.S.-headquartered real estate investment trust specializing in owning, operating, and redeveloping high-quality multifamily residential apartment communities. It operates across major U.S. metropolitan markets, catering to a diverse tenant base including young professionals, families, and middle-to-high income households.

CLOV vs UDR — Head-to-Head

Bigger by revenue
CLOV
CLOV
1.1× larger
CLOV
$487.7M
$425.8M
UDR
Growing faster (revenue YoY)
CLOV
CLOV
+43.8% gap
CLOV
44.7%
0.9%
UDR
Higher net margin
UDR
UDR
54.7% more per $
UDR
44.6%
-10.1%
CLOV
Faster 2-yr revenue CAGR
CLOV
CLOV
Annualised
CLOV
18.6%
1.3%
UDR

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
CLOV
CLOV
UDR
UDR
Revenue
$487.7M
$425.8M
Net Profit
$-49.3M
$189.8M
Gross Margin
Operating Margin
-10.1%
54.0%
Net Margin
-10.1%
44.6%
Revenue YoY
44.7%
0.9%
Net Profit YoY
-123.2%
147.2%
EPS (diluted)
$0.63

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLOV
CLOV
UDR
UDR
Q1 26
$425.8M
Q4 25
$487.7M
$433.1M
Q3 25
$496.6M
$431.9M
Q2 25
$477.6M
$425.4M
Q1 25
$462.3M
$421.9M
Q4 24
$337.0M
$422.7M
Q3 24
$331.0M
$420.2M
Q2 24
$356.3M
$415.3M
Net Profit
CLOV
CLOV
UDR
UDR
Q1 26
$189.8M
Q4 25
$-49.3M
$222.9M
Q3 25
$-24.4M
$40.4M
Q2 25
$-10.6M
$37.7M
Q1 25
$-1.3M
$76.7M
Q4 24
$-22.1M
$-5.0M
Q3 24
$-9.2M
$22.6M
Q2 24
$7.4M
$28.9M
Gross Margin
CLOV
CLOV
UDR
UDR
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
24.5%
Q2 24
30.3%
Operating Margin
CLOV
CLOV
UDR
UDR
Q1 26
54.0%
Q4 25
-10.1%
64.1%
Q3 25
-4.9%
17.7%
Q2 25
-2.2%
18.2%
Q1 25
-0.3%
29.0%
Q4 24
-6.4%
15.7%
Q3 24
-2.7%
16.6%
Q2 24
2.0%
16.5%
Net Margin
CLOV
CLOV
UDR
UDR
Q1 26
44.6%
Q4 25
-10.1%
51.5%
Q3 25
-4.9%
9.4%
Q2 25
-2.2%
8.9%
Q1 25
-0.3%
18.2%
Q4 24
-6.6%
-220.5%
Q3 24
-2.8%
5.4%
Q2 24
2.1%
7.0%
EPS (diluted)
CLOV
CLOV
UDR
UDR
Q1 26
$0.63
Q4 25
$0.67
Q3 25
$0.12
Q2 25
$0.11
Q1 25
$0.23
Q4 24
$-0.01
Q3 24
$0.06
Q2 24
$0.08

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLOV
CLOV
UDR
UDR
Cash + ST InvestmentsLiquidity on hand
$78.3M
$1.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$308.7M
$3.3B
Total Assets
$541.0M
$10.3B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLOV
CLOV
UDR
UDR
Q1 26
$1.3M
Q4 25
$78.3M
$1.2M
Q3 25
$1.2M
Q2 25
$1.5M
Q1 25
$1.3M
Q4 24
$194.5M
$1.3M
Q3 24
$288.0M
$2.3M
Q2 24
$254.8M
$2.8M
Total Debt
CLOV
CLOV
UDR
UDR
Q1 26
Q4 25
$5.8B
Q3 25
$5.8B
Q2 25
$5.8B
Q1 25
$5.8B
Q4 24
$5.8B
Q3 24
$5.9B
Q2 24
$5.8B
Stockholders' Equity
CLOV
CLOV
UDR
UDR
Q1 26
$3.3B
Q4 25
$308.7M
$3.3B
Q3 25
$340.9M
$3.3B
Q2 25
$344.2M
$3.3B
Q1 25
$336.1M
$3.3B
Q4 24
$341.1M
$3.4B
Q3 24
$342.2M
$3.5B
Q2 24
$324.9M
$3.7B
Total Assets
CLOV
CLOV
UDR
UDR
Q1 26
$10.3B
Q4 25
$541.0M
$10.6B
Q3 25
$559.7M
$10.6B
Q2 25
$575.0M
$10.6B
Q1 25
$583.7M
$10.7B
Q4 24
$580.7M
$10.9B
Q3 24
$653.0M
$11.1B
Q2 24
$674.2M
$11.1B
Debt / Equity
CLOV
CLOV
UDR
UDR
Q1 26
Q4 25
1.77×
Q3 25
1.78×
Q2 25
1.74×
Q1 25
1.74×
Q4 24
1.69×
Q3 24
1.67×
Q2 24
1.55×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLOV
CLOV
UDR
UDR
Operating Cash FlowLast quarter
$-66.9M
Free Cash FlowOCF − Capex
$-69.0M
FCF MarginFCF / Revenue
-14.1%
Capex IntensityCapex / Revenue
0.4%
4.9%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-69.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLOV
CLOV
UDR
UDR
Q1 26
Q4 25
$-66.9M
$902.9M
Q3 25
$12.1M
$234.9M
Q2 25
$5.4M
$250.3M
Q1 25
$-16.3M
$156.2M
Q4 24
$34.8M
$876.8M
Q3 24
$50.0M
$230.3M
Q2 24
$44.8M
$238.5M
Free Cash Flow
CLOV
CLOV
UDR
UDR
Q1 26
Q4 25
$-69.0M
$650.0M
Q3 25
$11.4M
$164.6M
Q2 25
$4.8M
$190.1M
Q1 25
$-16.5M
$103.2M
Q4 24
$33.3M
$627.0M
Q3 24
$49.6M
$161.3M
Q2 24
$44.4M
$171.1M
FCF Margin
CLOV
CLOV
UDR
UDR
Q1 26
Q4 25
-14.1%
150.1%
Q3 25
2.3%
38.1%
Q2 25
1.0%
44.7%
Q1 25
-3.6%
24.5%
Q4 24
9.9%
148.3%
Q3 24
15.0%
38.4%
Q2 24
12.5%
41.2%
Capex Intensity
CLOV
CLOV
UDR
UDR
Q1 26
4.9%
Q4 25
0.4%
58.4%
Q3 25
0.1%
16.3%
Q2 25
0.1%
14.2%
Q1 25
0.0%
12.6%
Q4 24
0.5%
59.1%
Q3 24
0.1%
16.4%
Q2 24
0.1%
16.2%
Cash Conversion
CLOV
CLOV
UDR
UDR
Q1 26
Q4 25
4.05×
Q3 25
5.81×
Q2 25
6.64×
Q1 25
2.04×
Q4 24
Q3 24
10.19×
Q2 24
6.04×
8.26×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLOV
CLOV

Segment breakdown not available.

UDR
UDR

Rental income$423.3M99%
Joint venture management and other fees$2.5M1%

Related Comparisons